| Name | 1-(7-bromo-3,4-dihydro-1h-isoquinolin-2-yl)-2,2,2-trifluoroethanone |
|---|---|
| Synonyms |
Ethanone, 1-(7-bromo-3,4-dihydro-2(1H)-isoquinolinyl)-2,2,2-trifluoro-
7-bromo-2-trifluoroacetyl-1,2,3,4-tetrahydroisoquinoline 1-(7-Bromo-3,4-dihydro-2(1H)-isoquinolinyl)-2,2,2-trifluoroethanone |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 392.9±42.0 °C at 760 mmHg |
| Molecular Formula | C11H9BrF3NO |
| Molecular Weight | 308.095 |
| Flash Point | 191.4±27.9 °C |
| Exact Mass | 306.981964 |
| PSA | 20.31000 |
| LogP | 4.02 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.533 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933499090 |
|
~85%
181514-35-2 |
| Literature: NOVARTIS AG Patent: WO2008/76954 A2, 2008 ; Location in patent: Page/Page column 51 ; WO 2008/076954 A2 |
|
~94%
181514-35-2 |
| Literature: Stokker Tetrahedron Letters, 1996 , vol. 37, # 31 p. 5453 - 5456 |
|
~%
181514-35-2 |
| Literature: Taisho Pharmaceutical Co., Ltd.; BUSUJIMA, Tsuyoshi; OI, Takahiro; TANAKA, Hiroaki; SHIRASAKI, Yoshihisa; IWAKIRI, Kanako; SATO, Nagaaki; TOKITA, Shigeru Patent: EP2687507 A1, 2014 ; Location in patent: Paragraph 0209 ; |
|
~%
181514-35-2 |
| Literature: Stokker Tetrahedron Letters, 1996 , vol. 37, # 31 p. 5453 - 5456 |
|
~%
181514-35-2 |
| Literature: Pfizer Inc Patent: US2005/182079 A1, 2005 ; Location in patent: Page/Page column 11 ; |
| Precursor 6 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933499090 |
|---|---|
| Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |